Author Archives: Alliance HealthCare Services

Akumin Announces Closing of Acquisition of Alliance Healthcare Services and Related Financing

Acquisition creates the most comprehensive radiology and oncology solutions provider in the U.S. and a catalyst for continued innovative growth

Plantation, FL — September 1, 2021 – Akumin Inc. (NASDAQ/TSX: AKU) (“Akumin”), a premier provider of outpatient radiology services in the U.S., announced today that it has completed its previously announced acquisition of Alliance HealthCare Services, Inc. (“Alliance”), a leading national provider of radiology and oncology solutions to hospitals, health systems and physician groups, through its wholly-owned indirect subsidiary, Akumin Corp (the “Acquisition”). Akumin now offers the most comprehensive radiology and oncology solutions to patients in the U.S., operating in 46 states, with more than 1,000 hospital and health system customers, 154 independent outpatient radiology centers and 34 radiation therapy centers, and has over 4,000 team members serving more than two million radiology and oncology patient visits annually.

“When we announced our acquisition of Alliance and the plan to bring these two great companies together, we shared our belief that this combination is very exciting in the context of a changing healthcare ecosystem – continuing not only to shift toward outpatient, price-transparent, value-based care, but also toward increasingly integrated hospitals, health systems and physician groups,” said Riadh Zine, Chairman and Co-CEO. “Today, we celebrate our first steps together as a powerhouse in outpatient healthcare solutions, and a catalyst for continued healthcare transformation in the U.S.”

“As the partner of choice to hospitals, health systems and physicians in outpatient imaging and cancer care services, our incredible teams across the country will continue putting patient experience at the center of all we do,” said Rhonda Longmore-Grund, President and Co-CEO. “As one company, we will expand our solutions to hospital customers and partners with a focus on driving access, efficiency and innovation. We begin our integration today – and look forward to sharing our progress, successes and growth.”

“We are looking forward to working with Tahoe, the Alliance seller, both as a shareholder and through Mr. Huang, their representative on our board of directors,” Mr. Zine continued. “We are excited for our new partnership with Stonepeak, who provided their full support and capital commitment for this transaction, with additional capital available for future growth. We also want to thank the investor base in our senior secured notes who participated in our growth to date and in the funding of this transaction.”

The purchase price for Alliance was funded with cash on hand, assumption of debt, equity issued to the seller, debt and equity commitments from Stonepeak (the “Stonepeak Financing”) and proceeds from Akumin’s offering of 2028 senior secured notes which closed in escrow on August 9, 2021.

For the Stonepeak Financing, Stonepeak Magnet Holdings LP (“Stonepeak Magnet”) purchased on September 1, 2021 US$340,000,000 (CAD$428,978,000) principal amount of unsecured notes of Akumin Corp. (the “Financing Notes”), together with warrants to purchase 17,114,093 common shares of Akumin (the “Financing Warrants”) and 3,500,000 common shares of Akumin (the “Financing Shares”). For a three-year period following the closing, provided certain conditions are met, Akumin Corp. will be permitted to draw up to an additional US$349,570,000 from Stonepeak. The Financing Notes, Financing Warrants, Financing Shares, and additional draws were made available on the terms described in Akumin’s press release dated June 25, 2021.

Stonepeak Magnet purchased the Financing Shares at a price of US$2.98 per share (CAD$3.76 per share), for total consideration of US$10,430,000 (CAD$13,159,531). No consideration was paid for the Financing Warrants. The 17,114,093 common shares of Akumin which may be acquired upon the exercise of the Financing Warrants have a purchase price of US$2.98 per share (or CAD$3.76 per share), for a total purchase price of US$50,999,997.10 (or CAD$64,346,696.34).

In addition, upon closing of the Acquisition, the US$375,000,000 of proceeds raised from Akumin’s private offering of 7.500% senior secured notes due 2028 (the “Senior Notes”) that closed on August 9, 2021 (the “Private Offering”) were released to Akumin given the satisfaction of the applicable escrow release conditions, and the obligations of Akumin Escrow Inc. under the Senior Notes were assumed by Akumin upon liquidation of Akumin Escrow Corp. into Akumin. All proceeds raised from the Private Offering were used to pay a portion of the cash closing price for the Acquisition.

Upon closing of the Acquisition, Akumin has 89,026,997 common shares issued and outstanding, including the Financing Shares issued to Stonepeak at a price of US$2.98 per share (CAD$3.76 per share) and the issuance of 14,223,570 common shares issued to the seller at a price of US$2.98 per share (CAD$3.76 per share) for aggregate consideration of US$42,416,038.60 (CAD$53,518,223.20).

All CAD$ have been calculated based on an exchange rate of 1.2617, being the Bank of Canada daily average exchange rate on August 31, 2021.

Management Composition Post-Closing of Acquisition

As previously announced, upon closing, Riadh Zine, Akumin’s former President and Chief Executive Officer, was named Chairman and Co-Chief Executive Officer of Akumin. Rhonda Longmore-Grund, Alliance’s former President and Chief Executive Officer, was named President and Co-Chief Executive Officer of Akumin. Mr. Zine and Ms. Longmore-Grund will remain actively involved in Akumin’s strategy and business operations in these new roles. Stan Dunford, former chairman of Akumin’s board of directors, has been named chairman emeritus and will continue as a member of Akumin’s board of directors as Riadh Zine assumes the role of chairman.

In addition, William Larkin, Alliance’s former Chief Financial Officer, was named Chief Financial Officer of Akumin and Mohammad Saleem, Akumin’s former Chief Financial Officer, was named Senior Vice President of Financial Reporting. Richard Jones was named President of the combined company’s Radiology services; he was formerly Alliance HealthCare Radiology President. Douglas McCracken was named the President of the combined company’s Oncology services; he was formerly Alliance Oncology President. Other senior officer positions will be announced as determined in due course.

Director Appointment

Further, as previously announced, upon closing of the Acquisition, Akumin’s board of directors exercised its right in accordance with applicable corporate laws to increase the size of the board from five members to six and to appoint Haichen Huang, a nominee of Thaihot Investment Co., LTD, the seller of Alliance, to fill the vacancy at closing.

About Akumin Inc.

Akumin Inc. is a corporation under the laws of Ontario with its U.S. head office at 8300 W Sunrise Blvd., Plantation, Florida, 33322 and its Canadian head office at 151 Bloor Street West, Suite 603, Toronto, Ontario, M5S 1S4. Akumin is a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service line needs. With the acquisition of Alliance HealthCare Services, Akumin now provides (1) freestanding, fixed-site outpatient diagnostic imaging services through a network of more than 170 owned and/or operated independent imaging centers located in 11 states; and (2) outpatient radiology and oncology solutions to more than 1,000 hospitals and health systems in 46 states. By combining clinical and operational expertise with the latest advances in technology and information systems, Akumin and its ~4,000 Team Members facilitate more efficient and effective diagnosis and treatment for patients and their providers in 46 states. Akumin’s imaging procedures include MRI, CT, positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures; our cancer care services include a full suite of radiation therapy and related offerings. For more information, visit www.akumin.com and www.alliancehealthcareservices-us.com.

About Stonepeak

Stonepeak Magnet is organized under the laws of Delaware and its head office is 55 Hudson Yards, 550 W. 34th Street, 48th Floor, New York, New York 10001. Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately US$37 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, and to have a positive impact on the communities in which it operates. Stonepeak sponsors investment vehicles focused on private equity and credit. The firm provides capital, operational support, and committed partnership to sustainably grow investments in its target sectors, which include transport and logistics, communications, water, energy transition, and power and renewable energy. Stonepeak is headquartered in New York with offices in Houston, Austin and Hong Kong. For more information, please visit www.stonepeakpartners.com. An early warning report will be filed by Stonepeak Magnet in accordance with applicable securities laws and will be available on SEDAR at www.sedar.com or may be obtained directly from Sharon Kretchmar upon request at +1 416-601-8419. A Schedule 13D will be filed by Stonepeak Magnet in accordance with applicable U.S. securities laws and will be available on EDGAR at www.sec.gov.

Stonepeak Magnet did not previously own or control any Akumin securities. As a result of completing the purchase of the Financing Shares, Stonepeak Magnet, together with its joint actors, owns and controls approximately 3.93% of currently outstanding common shares of Akumin immediately following the closing of transactions occurring on September 1, 2021. If the Financing Warrants are fully exercised, then combined with the common shares of Akumin held by Stonepeak Magnet, Stonepeak Magnet would, together with its joint actors, have ownership and control over 20,614,093 common shares of Akumin, representing approximately 19.42% of the common shares of Akumin on a partially diluted basis. The proposed acquisition by Stonepeak Magnet was made in the context of its overall investment purposes. Stonepeak Magnet holds all of its interest in Akumin for investment purposes and expects to review from time to time its investment in Akumin and may, depending on the market and other conditions: (i) purchase additional common shares of Akumin, options or related derivatives in the open market, in privately negotiated transactions or otherwise; (ii) sell all or a portion of the shares of common shares of Akumin, options or related derivatives now beneficially owned or hereafter acquired by them; and (iii) engage in communications with, among others, one or more shareholders of Akumin, one or more officers of Akumin and/or one or more members of the board of directors of Akumin regarding Akumin and/or Stonepeak Magnet’s investment.

About Tahoe

Thaihot Investment Co. LTD, a wholly owned subsidiary of Tahoe Healthcare Management Limited, is organized under the laws of the Cayman Islands and its head office is at the Offices of Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1-1205 Cayman Islands.

Tahoe Investment Group, founded in 1996 by Mr. Qisen Huang, is an investment holding company headquartered in No.333 North Wusi Road, Fuzhou, Fujian Province, China. With offices in major Chinese business hubs including Beijing, Shanghai, Guangzhou, and Hong Kong, Tahoe Investment Group holds a diversified portfolio of assets in various industries including real estate development, financial services, healthcare, and property management. Tahoe Group, in which Tahoe Investment Group holds a controlling ownership, is one of the leading real-estate developers in China listed on the Shenzhen Stock Exchange. For more information, please visit www.tahoecn.com.

An early warning report will be filed by Tahoe in accordance with applicable securities laws and will be available on SEDAR at www.sedar.com or may be obtained directly from Jinpeng Li upon request at +8618610278041. A Schedule 13D will be filed by Tahoe in accordance with applicable U.S. securities laws and will be available on EDGAR at www.sec.gov.

Tahoe did not previously own or control any Akumin securities. As a result of completing the sale of Alliance to Akumin, Tahoe owns and controls approximately 14,223,570 common shares of Akumin, representing approximately 15.97% of the currently outstanding common shares of Akumin immediately following the closing of transactions occurring on September 1, 2021. Tahoe holds all of its interest in Akumin for investment purposes and expects to review from time to time its investment in Akumin and may, depending on the market and other conditions: (i) purchase additional common shares of Akumin, options or related derivatives in the open market, in privately negotiated transactions or otherwise; (ii) sell all or a portion of the shares of common shares of Akumin, options or related derivatives now beneficially owned or hereafter acquired by them; and (iii) engage in communications with, among others, one or more shareholders of Akumin, one or more officers of Akumin and/or one or more members of the board of directors of Akumin regarding Akumin and/or Tahoe’s investment.

Forward-Looking Information

Certain information in this press release constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Forward-looking statements contained in this press release include, without limitation, statements regarding Akumin’s ability to draw additional funds from Stonepeak and the use of proceeds therefrom and appointments of other senior officers. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events.

Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Akumin as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including, but not limited to, the factors described in greater detail in the “Risk Factors” section of Akumin’s Annual Information Form dated March 31, 2021, which is available at www.sedar.com and www.sec.gov. These factors are not intended to represent a complete list of the factors that could affect Akumin; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and Akumin expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Key Contacts

For Akumin Investors
R. Jeffrey White
Investor Relations
866-640-5222
jeffrey.white@akumin.com

For Media & Industry
Tracy Wiese
Chief Strategy & Marketing Officer
949-877-4512
twiese@aiq-us.com

Alliance Healthcare Services Announces Acquisition by and Integration with Akumin

Acquisition will create the most comprehensive radiology and oncology solutions provider in the U.S. and a catalyst for continued innovative growth in the industry

IRVINE, CA — June 25, 2021 – Alliance HealthCare Services, Inc. (“Alliance”), a leading national provider of radiology and oncology solutions to hospitals, health systems and physician groups, announced today that it has entered into an agreement to be acquired for $820 million by Akumin Inc. (NASDAQ/TSX: AKU), a premier provider of freestanding outpatient radiology services in the U.S. The closing of the transaction is expected in third quarter of 2021, subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions.

Upon the closing of the transaction, the combined company will offer the most comprehensive radiology and oncology solutions to patients in the U.S., operating in 46 states, with more than 1,000 hospital and health system customers, 154 independent outpatient radiology centers and 34 radiation therapy centers. The combined company expects to have over 4,000 team members serving more than two million radiology and oncology patient visits annually.

“Bringing together the best of both organizations for the benefit of our patients, partners and customers is truly exciting,” said Rhonda Longmore-Grund, President and CEO of Alliance. “Alliance brings an over 30-year history of successful radiology and oncology partnerships with hospitals, health systems and physicians; and Akumin has built and continues to grow its premier outpatient imaging practice. Together we will offer patients and customers profound value unlike any other healthcare solutions company – and we can’t wait to get started.”

“We have always said Akumin’s vision is to drive patient-centered innovation, service delivery standardization, and exceptional healthcare value, all in an outpatient care setting,” said Riadh Zine, President and CEO of Akumin. “The acquisition of Alliance is transformative in a changing healthcare ecosystem that continues to shift toward outpatient, price-transparent, value-based care. There’s no other organization that has the complement of attributes we will offer together as outpatient healthcare services experts, in particular with Alliance’s longstanding hospital and health system relationships and Akumin’s freestanding operational expertise.”

“We thank the Alliance team for five years of partnership, and we look forward to the success we know Akumin and Alliance will achieve as a combined organization,” said Qisen Huang, Chairman and Founder of Tahoe Investment Group. Tahoe has been majority owner of Alliance since 2016 and will on closing transition to a minority ownership position in the newly combined, publicly traded entity.

The acquisition has been facilitated for Alliance with the assistance of Citigroup Global Markets, Inc. and SVB Leerink LLC, as financial advisors, and Ropes & Gray LLP and Osler, Hoskin & Harcourt LLP, as legal advisors. Stikeman Elliott LLP and McDermott Will & Emery LLP acted as legal advisors, and PricewaterhouseCoopers LLP as financial advisors, to Akumin.

About Alliance HealthCare Services

Alliance HealthCare Services is a leading national provider of outsourced advanced radiology and radiation therapy services across 45 states in the U.S. Alliance partners with more than 1,000 hospitals, health systems and physician practices to provide a full continuum of solutions, including onsite outpatient services and comprehensive service line management. Alliance’s ~2,500 Team Members deliver exceptional customer and patient care via more than 600 diagnostic radiology and radiation therapy systems. For more information, visit www.alliancehealthcareservices-us.com

About Akumin Inc.

Akumin is a leading provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States with a network of 137 owned and/or operated imaging centers located in Florida, Texas, Pennsylvania, Delaware, Illinois, Kansas, Georgia, and Massachusetts. By combining our clinical expertise with the latest advances in technology and information systems, our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. Our imaging procedures include MRI, CT, positron emission tomography (PET), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures, performed with the help of over 1,500 team members. For more information, visit www.akumin.com.

Contact

Tracy Wiese
Chief Strategy & Marketing Officer
Alliance HealthCare Services
949.242.5767
twiese@aiq-us.com

Alliance Cancer Care Colorado at Red Rocks Partners with SCL Health

Cancer Care Center Offers Advanced Radiation Therapy Treatments in a Comfortable and Convenient Outpatient Setting

IRVINE, CA — May 3, 2021 – Alliance Oncology, a division of Alliance HealthCare Services, a leading national provider of outsourced healthcare services, announced that their cancer care center in Golden, Colorado has formed a partnership with SCL Health, a faith-based, nonprofit health system serving patients primarily in Colorado and Montana.

Alliance Cancer Care Colorado at Red Rocks, located in the Red Rocks Medical Center in Golden Colorado, opened in November 2010 and is a multidisciplinary outpatient radiation oncology center that offers high-quality cancer care in a convenient, home-like setting. The new partnership brings the Cancer Centers of Colorado Lutheran Medical Center Radiation Oncology services on-site – including radiation oncologists Julie A. Carlson, M.D. and Tyler J. Kemmis, M.D., effective May 3.

“Our team at Alliance is excited to be partnering with SCL Health, and in particular we want to warmly welcome Drs. Carlson and Kemmis to the on-site care team,” said Douglas McCracken, President of Alliance Oncology. “Supporting each patient via education and evidence-based medicine, and providing compassionate care during a challenging time – these are commitments we share as we continue to serve the Golden and surrounding communities.”

“Across the US, we work side by side with more than a thousand hospitals to deliver effective and efficient diagnostic radiology, radiation therapy and related services,” added Rhonda Longmore-Grund, President and CEO of Alliance HealthCare Services. “We believe it is the best of both worlds: a focus on each unique community, partnership and patients, supported by national resources. We’re thrilled to welcome SCL as an Alliance HealthCare Services partner.”

Alliance Cancer Care Colorado at Red Rocks is located at 400 Indiana Street, Suite 220, Golden, Colorado, 80401. For more information, or to make an appointment with Dr. Carlson or Dr. Kemmis, please call (720) 420-3300 or visit www.accredrocks.com.

About Alliance HealthCare Services

Alliance HealthCare Services is a leading national provider of outsourced healthcare solutions, with expertise in radiology, oncology, and interventional services. Alliance partners with hospitals, health systems and providers to bring a full continuum of services to local communities, including mobile, interim, fixed-site, and comprehensive service line management as well as ASCs and joint venture partnerships. Alliance operates more than 600 diagnostic radiology, radiation therapy, and interventional systems, including more than 70 fixed-site radiology locations, more than 40 cancer care centers, and more than 20 pain management/interventional procedures clinics. Alliance provides quality clinical services for over 1,100 hospitals and other healthcare partners in 47 states, where approximately 2,750 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit www.alliancehealthcareservices-us.com

About SCL Health Lutheran Medical Center

Lutheran Medical Center is a community-based, 338-bed acute-care hospital located in Wheat Ridge, CO. Local and national ratings organizations regularly recognize Lutheran for clinical excellence, patient safety and patient experience.

Lutheran’s premier services include a birthing center, Heart and Neurovascular Center, robotic surgery, Comprehensive Stroke Center, Cancer Centers of Colorado, Orthopedics, a Level II Trauma Center and emergency services including the first Senior Emergency Room in Colorado. Senior-focused services also include a dedicated Senior Behavioral Health unit. Lutheran operations include West Pines, Lutheran Hospice, and the Spine Center at Denver West.

About SCL Health

SCL Health is a faith-based, nonprofit healthcare organization dedicated to improving the people and communities it serves. Founded by the Sisters of Charity of Leavenworth in 1864, its health network provides comprehensive, coordinated care through eight hospitals, more than 150 physician clinics, and home health, hospice, mental health, and safety-net services primarily in Colorado and Montana.

Contacts
Stephanie Audain
Alliance Oncology
A Division of Alliance HealthCare Services
615-263-7816
SAudain@AllianceOncology.com

Tracy Wiese
Chief Strategy & Marketing Officer
Alliance HealthCare Services
949.242.5767
twiese@aiq-us.com

Alliance Radiology Finalizes Acquisition of Four PET/CT Locations

National Leader in Radiology Services Acquires Centers from Molecular Imaging Technologies

September 16, 2020 IRVINE, Calif. – Alliance HealthCare Radiology (“Alliance Radiology”), a subsidiary of Alliance HealthCare Services, announced today the acquisition of four PET/CT locations owned by Molecular Imaging Technologies (“MIT”). The four locations are: Affiliated PET Systems (Silver Spring, MD), Doylestown PET Associates (Doylestown, PA), Decatur Health Imaging (Decatur, AL), and Monroe PET (Monroe, LA). Alliance Radiology offers a full range of radiology solutions across the U.S. in partnership with hospitals, health systems, and physician groups focused on superior patient care.

“We feel fortunate to add four well-known and well-regarded PET/CT diagnostic imaging locations to the Alliance Radiology family,” said Alliance Radiology President Rich Jones. “Each site has an established reputation within its local community for providing patients with high-quality and high-value medical imaging, and each is located near where Alliance Radiology offers other imaging services. We look forward to supporting each location’s continued service to patients and providers.”

Alliance Radiology is a leading national provider of PET/CT services, employing the most PET/CT technologists and operating the largest number of PET/CT imaging systems in the U.S. Alliance Radiology delivers a 99% average patient satisfaction in PET/CT and commits to maintaining superior quality standards while integrating the four Molecular Imaging Technologies locations. For Alliance Radiology, this acquisition grows its overall national and regional services and continues its mission to deliver exceptional care to patients and essential solutions to partners.

“When it came time for us to transition these centers, we wanted to be sure they – and our employees, partners and referring providers – were in good hands. We’re pleased to have chosen Alliance Radiology; like us, they are focused on great care and service in their communities,” said Gary Moyers, Senior Vice President of Operations at Molecular Imaging Technologies.

“Alliance has expertise in radiology, oncology and interventional pain management – so we knew there would be great synergy. We’re glad they are here to help carry on excellent care and great partnering within these four communities,” said Tammy Hobbs, Chief Financial Officer at Molecular Imaging Technologies.

Laura Stark, Senior Vice President of Operations for Alliance Radiology, summed it up this way: “Today we celebrate progress and partnership. I’d like to thank all our frontline caregivers, including those joining us from MIT, for their continued compassion, grace, and tireless service to our patients and communities at a time when it matters most.”

About Alliance HealthCare Services

Alliance HealthCare Services is a leading national provider of outsourced healthcare solutions, with expertise in radiology, oncology, and interventional services. Alliance partners with hospitals, health systems and providers to bring a full continuum of services to local communities, including mobile, interim, fixed-site, and comprehensive service line management as well as ASCs and joint venture partnerships. Alliance operates more than 600 diagnostic radiology, radiation therapy, and interventional systems, including more than 70 fixed-site radiology locations, more than 40 cancer care centers, and more than 20 pain management/interventional procedures clinics. Alliance provides quality clinical services for over 1,100 hospitals and other healthcare partners in 47 states, where approximately 2,750 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit www.alliancehealthcareservices-us.com

About Molecular Imaging Technologies

Founded in 1997, Molecular Imaging Technologies is a Positron Emission Tomography/Computed Tomography (“PET/CT”) services provider. As a pioneer in the provision of PET/CT equipment and related services, MIT partners with academic institutions, systems, hospitals, networks, physician groups and independent imaging facilities to create professional, caring, and compassionate PET/CT environments. For more information, please visit www.molecularimagingtech.com

Contacts
Tracy Wiese
Chief Strategy & Marketing Officer
Alliance HealthCare Services
949.242.5767
twiese@aiq-us.com

Alliance Oncology Announces New State-of-the-Art Cancer Center in Northwest Alabama

September 01, 2020 NASHVILLE, Tenn. – Alliance Oncology, a division of Alliance HealthCare Services, a leading national provider of outsourced healthcare services, announced the opening of Singing River Cancer Center (SRCC). SRCC will be a part of Alliance Cancer Care, one of the largest radiation cancer networks in the southeast with over 50 years of combined experience offered at five different locations throughout Northern Alabama.

“We are extremely excited about the opening of the new Singing River Cancer Center,” said Douglas McCracken, President of Alliance Oncology. “SRCC brings together an extensive suite of oncology services, multidisciplinary experts, and advanced technology to give residents of the Shoals area and surrounding communities first-class cancer care in one convenient location.”

Located in Florence, Alabama, SRCC is a 45,000 square foot state-of-the-art cancer center that will offer innovative technology and collaborative care in a community setting and serve patients locally and throughout greater Northwest Alabama. SRCC occupants will include Alliance Cancer Care (ACC), Clearview Cancer Institute (CCI), Helen Keller Imaging, and Surgical Associates of the Shoals.

For patients choosing radiation therapy treatments, ACC offers several types of radiation therapy designed to treat all forms and stages of cancer. Their board-certified radiation oncologists, physicists, dosimetrists, therapists, navigators, nursing staff, and counselors provide a custom treatment plan and resources that address each patient’s unique needs. Treatments include external beam radiation therapy (EBRT), intensity-modulated radiation therapy (IMRT), 3-D conformal therapy, image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), and brachytherapy. Treatments are outpatient and noninvasive, with minimal to no recovery time.

Clearview Cancer Institute focuses on the diagnosis, treatment, follow-up after treatment, and prevention of all types of cancers and blood diseases. Their board-certified medical oncologists and hematologists provide the latest in cancer treatment options including immunotherapy, chemotherapy, and hormone therapy. Clearview will also offer a complete spectrum of state-of-the-art radiologic modalities, such as a wide-bore MRI, CT, X-ray, Ultrasound, Nuclear Medicine, and PET-CT. CCI offers many educational and complementary services for their patients undergoing cancer treatment including stage I-IV clinical trials, genetic testing and counseling, social services, financial services, lung cancer screening programs, and survivorship programs.

Helen Keller Hospital will provide 3-D Mammography services. They are the only organization to offer an on-site breast nurse navigator who works with the physicians to assist patients with a variety of needs from pre-screening through diagnosis and beyond.

Surgeons at Surgical Associates of the Shoals deliver surgical care in an experienced, individualized way, while still providing the latest, greatest excellence in surgery care their patients need. As members of the American College of Surgeons and board-certified by the American Board of Surgery, their surgeons are well versed in all areas of general surgery, including breast, colon/rectal​, endoscopy, skin and soft tissue, endocrine, minimally invasive, robotics, foregut, and in select areas of vascular and hepatobiliary surgery.

SRCC is proud to offer residents in the Shoals area and surrounding communities high-quality, multidisciplinary cancer care. With multiple services under one roof, patients can save time and money by having their cancer treatment close to home. In addition to healthcare and physician offices, SRCC will feature a café, chapel, and ample free parking.

Singing River Cancer Center is located at 180 Cox Creek Parkway South, Florence, Alabama 35630, and opens this month. For more information, please visit www.SingingRiverCancerCenter.com.

About Alliance HealthCare Services

Alliance HealthCare Services is a leading national provider of outsourced healthcare solutions, with expertise in radiology, oncology, and interventional services. We partner with healthcare providers, systems, and hospitals to provide a full continuum of services, including mobile, interim, fixed-site, and comprehensive service line management as well as ASCs and joint venture partnerships. Alliance operates more than 600 diagnostic radiology, radiation therapy, and interventional systems, including more than 70 fixed-site radiology locations, more than 40 cancer care centers, and more than 20 pain management/interventional procedures clinics. Alliance provides quality clinical services for over 1,100 hospitals and other healthcare partners in 47 states, where approximately 2,750 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit www.alliancehealthcareservices-us.com.

Contact:
Stephanie Audain
Sr. Manager, Marketing
Alliance Oncology, a division of Alliance HealthCare Services
615-263-7816
SAudain@AllianceOncology.com